Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates.


Bisphosphonate has clearly become one of the major risk factors of ONJ. Concerns about ONJ are also seen in Asian countries including Korea. The use of serum CTX is not yet evidence based but the marker will be usable as a reference laboratory test in evaluating the risk of ONJ in the near future. Bagan et al. did a very interesting study with their… (More)
DOI: 10.1016/j.oraloncology.2008.11.010